Recent Updates
Recently added Catalysts
ACRS Positive Sentiment

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Thursday, May 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Aclaris Therapeutics will participate in the 2026 Jefferies Global Healthcare Conference on June 4, 2026. CEO Dr. Neal Walker and the senior leadership team will engage in a fireside chat. The event will be accessible via a live and archived webcast on Aclaris' website for at least 30 days.
Price reaction · baseline $4.58 (2026-05-27 close) · hit pre-market · clean, no other ACRS news in the window
day 0 close
-0.2%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aclaris is actively participating in a major healthcare conference.
  • The event provides a platform for leadership to share insights.
  • The webcast allows broader access to Aclaris' updates.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+181%
120-day peak, hindsight
Typical move
9.5%
average across 4 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
ATI-045
Phase 2 · Atopic Dermatitis

Full Press Release Details

WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday June 4, 2026, at 2:00 PM ET, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the 2026 Jefferies Global Healthcare Conference in New York, NY.
A live and archived webcast of this event will be accessible on theEvents pageof the Aclaris website,www.aclaristx.com. The webcast will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris onLinkedIn.

Aclaris Therapeutics Contact:

Will RobertsSenior Vice PresidentCorporate Communications and Investor Relations(484) 329-2125wroberts@aclaristx.com

Frequently Asked Questions

When is Aclaris participating in the Jefferies Conference?

Aclaris will participate on June 4, 2026, at 2:00 PM ET.

Who will represent Aclaris at the conference?

CEO Dr. Neal Walker and the senior leadership team will represent Aclaris.

How can I access the conference webcast?

The webcast will be available on Aclaris' website for at least 30 days.

What is Aclaris focusing on?

Aclaris is focused on developing treatments for immuno-inflammatory diseases.

ShareAdd on Google
Tags: ACRS Viatris Investor Conferences Healthcare Aclaris Therapeutics Jefferies Conference immuno-inflammatory diseases biopharmaceutical clinical-stage
Last updated: May 28, 2026

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$171M liquidity · $7M/mo burn
~25 mo
Minimal dilution risk
Lead asset
ATI-045Phase 2
Atopic Dermatitis →

Catalyst track record

+181%
best trade around ACRS's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for ACRS.

See every catalyst's timing & PoA →